Andelyn Biosciences is a pioneering Gene Therapy CDMO born out of Nationwide Children's Hospital Viral Vector Core. Our exper ... ts are globally recognized thought leaders with 15+ years of experience with AAV vector manufacturing. We have partnered in over 60+ US, EU and ROW clinical trials and innovated Zolgensma- the first FDA approved Gene Therapy for SMA. We are your full spectrum Gene Therapy partner, with capabilities for Viral Vector process and analytical development, small to large scale GMP manufacturing, Fill/Finish and quality release testing. We also offer plasmid manufacturing services and vector development (GMP, R&D and Tox grade). Our state-of-the-art 200,000 sq ft Commercial Manufacturing Facility will be operational in the Fall of 2022, offering clinical through commercial scale Drug Substance and Drug Product manufacturing services. As an affiliate organization of Nationwide Children’s Hospital, Andelyn Biosciences’ unique business model allows for reinvestment into pioneering gene therapy research conducted at the world-class Abigail Wexner Research Institute to uncover the next generation of cures for rare diseases. read more